Published August 16, 2011
Volume 19, Number 8

  • Hacienda’s IntegenX RapidHIT 200 Human Identification System, which will ship commercially in early 2012, will produce DNA profiles from mouth swabs and other samples in less than two hours, thanks in part to a new agreement with Promega Corporation to use that company’s reagents.    

    “The RapidHIT Human Identification System represents a highly automated and specialized integration of our STR amplification chemistry,” said Bill Linton, Promega’s chairman and chief executive officer. “The supply agreement with IntegenX gives law enforcement agencies and other organizations the choice to adopt powerful DNA-based human identification technology without adding the specialized infrastructure that’s usually required for a DNA lab.”    

    “Promega has been a great partner that we have worked with to optimize the use of their STR chemistry in our RapidHIT 200 system,” said Stevan Jovanovich, president and chief executive officer of IntegenX Inc. “The combination of IntegenX’s technology and Promega’s chemistry will help make the RapidHIT 200 the platform of choice for rapid human DNA identification.”
  • Ross Dress for Less, a national retailer with headquarters in Hacienda, is expanding its total of over 1,000 off-price apparel stores in 27 states by opening 12 new locations in the greater Chicago area on Saturday, October 8. The company will be creating approximately 600 jobs with the new stores.    

    “We are excited to be entering the Chicago area, which will significantly expand our national footprint,” said Michael Balmuth, vice chairman and chief executive officer. “With nearly 30 years of delivering unbeatable savings, along with twelve new stores conveniently located in established shopping centers, we are confident that Ross will be a terrific destination for Chicago-area customers to find great deals on name brands for the family and the home.
  • Hacienda’s ZELTIQ Aesthetics, Inc., has filed with the U.S. Securities and Exchange Commission regarding a proposed initial public offering of shares of its common stock. ZELTIQ is a medical technology company best known for its first product, the CoolSculpting system, which uses Cryolipolysis—a patented, clinically proven procedure that freezes fat cells without damaging skin—to reduce stubborn fat bulges which may not respond to diet or exercise. The number of shares to be offered and the price range for the offering have not yet been determined. Assisting with the proposed offering are J.P. Morgan Securities, Goldman, Sachs & Co., William Blair & Company, and Canaccord Genuity.

Also in this issue ...